FDA Cites 30 Compounding Centers for Safety Violations

The U.S. Food and Drug Administration (FDA) recently reprimanded a total of 30 compounding pharmacies for safety violations. The dangers were discovered during inspections at the facilities that came in the wake of numerous patients developing Fungal Meningitis as the result of receiving contaminated injections from a compounding center.

According to a story from NBC-Connecticut, the list of safety hazards found at the facilities included unsanitary rust and mold in rooms that were required to be sterile, failure to properly ventilate facilities, and laboratory employees wearing non-sterile work attire.

The actions came after 53 deaths and 733 illnesses were attributed to an outbreak of fungal meningitis caused by patients receiving steroid injections that were contaminated during the manufacturing process at a Massachusetts compounding facility.

Officials attributed the outbreak to the FDA’s inability to properly regulate and monitor the processes at compounding facilities. Since then, the FDA has stepped up its oversight of these facilities and will continue to perform regular inspections of their practices as well.

Incidents like this can often leave citizens wondering how they can protect themselves from the dangers of contaminated medications. The Connecticut Personal Injury Attorneys with Carter Mario Law Firm point out that one of the best ways is for patients to simply educate themselves about a medication a doctor has prescribed before beginning a regimen. Asking a pharmacist any questions you may have and reading any warning labels that are provided can help achieve this.